FDA Warns Abbott About Marketing Of HIV Drug
The U.S. Food and Drug Administration has sent a letter to Abbott Laboratories accusing it of overstating the efficacy of its HIV drug Kaletra, minimizing the drug's risks and including unsubstantiated...To view the full article, register now.
Already a subscriber? Click here to view full article